Skip to content.

Spotlight

Featured

Perspectives
Why we invested in OpenTrade
1 / 10
Read more
Perspectives
Why we invested in Infact
2 / 10
Read more
Perspectives
Why we invested in trumpet
3 / 10
Read more
Perspectives
Why we invested in Instinct
4 / 10
Read more
Perspectives
Why we invested in Treefera
5 / 10
Read more
Perspectives
Why we invested in Oriole Networks
6 / 10
Read more
Perspectives
Why we invested in Gridcog
7 / 10
Read more
Perspectives
Why we invested in OpenDialog
8 / 10
Read more
Perspectives
Why we invested in kennek?
9 / 10
Read more
Perspectives
Why we invested in tem.?
10 / 10
Read more

Web

The outlook for venture capital & tech in 2024

Christoph Ruedig on the BVCA 40th Anniversary Podcast Series

Read the article >
Web

Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT

UCLTF cell therapy startup Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT

Read the article >
Web

Leigh Brody, UCLTF Investor | Career in Discovery Podcast

Leigh Brody, UCLTF investor on TalentSingular’s ‘Careers in discovery’ podcast

Read the article >
Web

Bramble Energy among 23 deeptech startups primed to take off | Business Insider

Bramble Energy | Business Insider

Read the article >
Web

4th Nasdaq IPO for the UCL Technology Fund: Achilles Therapeutics listing 

Nasdaq

Read the article >
Web

Freeline Therapeutics Rings the Nasdaq Opening Bell in Celebration of its IPO

Nasdaq

Read the article >